Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lead Real Estate ADR | LRE | Oct 31, 2024 | 2.30 | +37.72 |
Leafly | LFLY | Oct 31, 2024 | 1.74 | -1.69 |
Leap Therapeutics | LPTX | Oct 31, 2024 | 3.74 | -10.31 |
Lear | LEA | Oct 31, 2024 | 95.76 | -2.11 |
LeddarTech | LDTC | Oct 31, 2024 | 0.25 | -5.66 |
Lee Enterprises | LEE | Oct 31, 2024 | 17.90 | -0.72 |
Legacy Housing | LEGH | Oct 31, 2024 | 24.80 | -2.67 |
LegalZoom.com | LZ | Oct 31, 2024 | 7.18 | -0.83 |
Legato Merger III | LEGT | Oct 31, 2024 | 10.26 | +0.10 |
Legend Biotech ADR | LEGN | Oct 31, 2024 | 45.02 | +1.69 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Oct 31, 2024 | 39.94 | +0.35 |
Leggett & Platt | LEG | Oct 31, 2024 | 12.00 | -1.07 |
Leidos | LDOS | Oct 31, 2024 | 183.16 | -1.39 |
LeMaitre Vascular | LMAT | Oct 31, 2024 | 88.39 | -0.74 |
Lemonade | LMND | Oct 31, 2024 | 23.77 | +26.77 |
LendingClub | LC | Oct 31, 2024 | 14.18 | -2.54 |
LendingTree | TREE | Oct 31, 2024 | 57.03 | -1.74 |
Lendway | LDWY | Oct 31, 2024 | 3.66 | +11.60 |
Lennar A | LEN | Oct 31, 2024 | 170.30 | -0.70 |
Lennar B | LEN-B | Oct 31, 2024 | 160.32 | -0.68 |
Lennox International | LII | Oct 31, 2024 | 602.57 | +0.35 |
LENSAR | LNSR | Oct 31, 2024 | 5.68 | +2.71 |
LENZ Therapeutics | LENZ | Oct 31, 2024 | 26.96 | -2.46 |
Leonardo DRS | DRS | Oct 31, 2024 | 30.07 | -4.96 |
Lesaka Technologies | LSAK | Oct 31, 2024 | 5.47 | -0.55 |
Leslies | LESL | Oct 31, 2024 | 2.69 | -5.61 |
Levi Strauss & Co A | LEVI | Oct 31, 2024 | 17.09 | -1.84 |
Lexaria Bioscience | LEXX | Oct 31, 2024 | 2.15 | -5.29 |
Lexeo Therapeutics | LXEO | Oct 31, 2024 | 7.90 | -4.53 |
Lexicon Pharmaceuticals | LXRX | Oct 31, 2024 | 1.95 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.